Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021:2181:269-286.
doi: 10.1007/978-1-0716-0787-9_16.

RNA Editing in Interferonopathies

Loredana Frassinelli  1 , Silvia Galardi  1 , Silvia Anna Ciafrè  1 , Alessandro Michienzi  2
Affiliations
Review

RNA Editing in Interferonopathies

Loredana Frassinelli et al. Methods Mol Biol. 2021.

Abstract

The type I interferonopathies comprise a heterogenous group of monogenic diseases associated with a constitutive activation of type I interferon signaling.The elucidation of the genetic causes of this group of diseases revealed an alteration of nucleic acid processing and signaling.ADAR1 is among the genes found mutated in patients with this type of disorders.This enzyme catalyzes the hydrolytic deamination of adenosines in inosines within a double-stranded RNA target (RNA editing of A to I). This RNA modification is widespread in human cells and deregulated in a variety of human diseases, ranging from cancers to neurological abnormalities.In this review, we briefly summarize the knowledge about the RNA editing alterations occurring in patients with mutations in ADAR1 gene and how these alterations might cause the inappropriate IFN activation.

Keywords: ADAR1; Double-stranded RNAs; Innate immunity; Interferonopathies; RNA editing; Type I interferon.

PubMed Disclaimer

Publication types

MeSH terms

Supplementary concepts

LinkOut - more resources